2025 annual financial data
Altimmune 2025 Operating margin
Altimmune 2025 operating margin with verified reported values.
Direct answer
Operating margin was -230,460.98%.
Operating income was -94,489,000 USD and net income was -88,093,000 USD.
Operating cash flow was -67,535,000 USD.
Get free Altimmune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 41,000 USD
- Operating income
- -94,489,000 USD
- Net income
- -88,093,000 USD
- Operating cash flow
- -67,535,000 USD